MARKETS / NASDAQ / Financials / Brokerage and capital markets / CME

NASDAQ · SECURITY & COMMODITY BROKERS, DEALERS, EXCHANGES & SERVICES · LARGE CAP

CME Group Inc. CME

19 fiscal years on record · USD · FY2025 reported · SEC filings only

Revenue

$6.5B

▲ 6.4% YoY

Net income

$4.1B

▲ 15.5% YoY

Free cash flow

$4.2B

▲ 16.6% YoY

Slide the table for earlier years · "·" marks a figure not available in our data for that year.

In brief

What this company does

CME Group enables clients to trade futures, options, cash and over-the-counter products, optimize portfolios and analyze data. Its exchanges offer benchmark products across interest rates, equity indexes, foreign exchange, and agricultural, energy and metals commodities. It also offers cash and repo fixed income trading via BrokerTec and spot and OTC foreign-exchange trading via EBS, and it operates a central counterparty clearing business. Its derivatives exchanges are CME, CBOT, NYMEX and COMEX. In 2025, 85% of its contract volume was from trades by its members. Through its derivatives clearing house, operated by CME, it provides clearing and settlement services for exchange-traded futures and options on futures contracts, exchange-traded swaps and OTC derivatives. In 2025, CME Group futures and options had an average daily volume of 28.1 million contracts. As of December 31, 2025, its global employee population consisted of approximately 3,875 employees, with 58% working in the U.S. and 42% in its various non-U.S. locations.

Written from the business description in CME GROUP INC.'s annual report to the U.S. Securities and Exchange Commission, filed 26 February 2026. Every sentence was checked against that document before publication.

Growth

USD 6.5B

Revenue, FY2025 · full 19-year series below

Revenue $B Net income $B

FY2025 · Revenue 6.5 · Net income 4.1

2.5B5.0B

2007201020132016201920222025

Compound annual growth

Revenue

+9.1%

+6.0%

+7.0%

+5.3%

Net income

+14.8%

+14.1%

+10.2%

EPS, diluted

+14.7%

+13.7%

+11.7%

+9.5%

Dividend / share

−16.2%

−3.3%

+0.2%

+11.9%

Returned to shareholders

+14.3%

+13.3%

+11.3%

+10.6%

3 yrs

5 yrs

10 yrs

15 yrs

Revenue compounded at +6.0% a year over the five years to FY2025 — but profit grew faster: net income at +14.1%, earnings per share at +13.7%.

Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.

Profitability

62 cents

of every revenue dollar became profit

Operating margin Net margin

FY2025 · Operating 64.9% · Net 62.5%

50%100%

200720162025

ROE

FY2025 · ROE 14.8%

5%10%15%

200720162025

Three returns, three denominators.

Return on equity14.8%

Return on assets2.4%

Return on capital employed11.5%

Gross margin·

Operating margin64.9%

Net margin62.5%

EBITDA·

Each USD of equity produced 15 cents of profit this year.

Cash & shareholders

USD 3.9B

returned in FY2025 · dividends + net buybacks

Free cash flow $B

FY2025 · FCF 4.2

2B3B

200720162025

Net buybacks $B Dividends $B

FY2025 · Dividends 3.9 · Net buybacks ·

2B3BDividendsNet buybacks

2007201020132016201920222025

Dividends paidUSD 3.9B

Net buybacks·

Share of profit96.6%

Consecutive raises·

USD 3.9B in dividends — 97% of the year's profit went back to shareholders.

Total assetsUSD 198.4B

EquityUSD 28.7B

CashUSD 4.4B

Gross debtUSD 0.00

Net debtUSD -4.4B

Current ratio1.03×

The company holds more cash than debt.

The 19-year record

19 fiscal years

Every figure from documents filed with the SEC · USD

EPS, diluted, dividend per share and shares outstanding are shown without shading, and a vertical line marks the year the share count changed — the series crosses a large, unexplained change in share count, so the years on either side are not on a comparable scale.

row low → row highnegative—not applicable◌not available in our data

CME, 19-year financial record
Metric	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007
Revenue $B	6.5	6.1	5.6	5.0	4.7	4.9	4.9	4.3	3.6	3.6	3.3	3.1	2.9	2.9	3.3	3.0	2.6	2.6	1.8
Operating income $B	4.2	3.9	3.4	3.0	2.6	2.6	2.6	2.6	2.3	2.2	2.0	1.8	1.6	1.7	2.0	1.8	1.6	1.6	1.1
EBITDA $B	◌	◌	◌	◌	◌	◌	◌	◌	◌	◌	◌	◌	◌	◌	◌	◌	◌	◌	◌
Income tax $B	1.3	1.0	0.9	0.8	0.7	0.6	0.6	0.8	−1.5	0.8	0.7	0.6	0.6	0.8	0.1	0.8	0.6	0.5	0.4
Net income $B	4.1	3.5	3.2	2.7	2.6	2.1	2.1	2.0	4.1	1.5	1.2	1.1	1.0	0.9	1.8	1.0	0.8	0.7	0.7
Free cash flow $B	4.2	3.6	3.4	3.0	2.3	2.5	2.4	2.3	1.7	1.6	1.4	1.2	1.2	1.1	1.2	1.2	0.9	1.0	0.7
EPS, diluted $	11.16	9.67	8.86	7.40	7.29	5.87	5.91	5.71	11.94	4.53	3.69	3.35	2.92	2.70	5.43	2.86	12.41	12.13	14.93
Dividend / sh $	5.00	10.40	9.65	8.50	5.90	5.90	5.50	4.55	6.14	5.65	4.90	4.40	4.40	3.70	1.12	0.92	4.60	9.60	3.44
Payout %	97	102	100	98	83	100	80	110	49	116	108	133	61	137	21	32	37	86	23
ROE %	14.8	13.2	12.0	9.9	9.8	8.0	8.1	8.1	19.0	7.5	6.0	5.4	4.6	4.2	8.7	4.8	4.3	4.6	5.4

Slide the table for earlier years. "—" not applicable · "◌" not available in our data.

Other companies filing in the same sector

UNH · BRK-A · BRK-B · CI · ELV · CNC

Provenance

Company facts, as filed

How we verify · 0 failures in 74 reconciliationsAUDITED

Reconciled in 19 of the 19 fiscal years we could check. Two checks were skipped: the balance sheet is not tagged before 2008.

EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidityCurrency consistency0 failures

ActivitySecurity & Commodity Brokers, Dealers, Exchanges & Services

Listed onNASDAQ

Incorporated inDelaware

Fiscal year endsDecember 31

Data on record since2007

CME Group Inc. CME

What this company does

Growth↗ Share

Profitability↗ Share

Cash & shareholders↗ Share

The 19-year record

Other companies filing in the same sector

Company facts, as filed

Growth

Profitability

Cash & shareholders